Clinical Trials Browser

Phase 3 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × ruxolitinib × Clear all

NCT05663827 2024-03-05

Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease

Phase 3 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma